Recombinant Human CLC1 Protein (HEK293)

CLC-1 (Chloride Channel 1) is a member of the CLC family of ion channels and transporters, playing a crucial role in maintaining cellular chloride homeostasis and electrical excitability in muscle and nerve tissues. Mutations in the CLCN1 gene, which encodes the CLC-1 protein, have been implicated in various myopathies, most notably myotonia congenital, a disorder characterized by delayed muscle relaxation following contraction. The study of CLC-1 recombinant protein is essential for understanding its structural and functional properties, as well as the molecular mechanisms underlying its role in ion transport. Research often involves various techniques, including site-directed mutagenesis, electrophysiology, and biochemical assays, to elucidate how specific amino acid changes affect ion flow and channel gating. Moreover, recombinant CLC-1 proteins serve as valuable tools for drug screening and the development of therapeutic interventions for chloride channel-related diseases. Understanding the dynamics of CLC-1 is not only significant for basic biophysics but also crucial for translational research aimed at developing strategies to ameliorate symptoms in affected patients. This field of study promises to advance our knowledge of muscle and nerve physiology and improve treatment options for myotonic disorders and other related conditions.